ITGAE and neoplasm: Consequently, this leads to the rejuvenation of MHC class II expression in antigen-presenting cells (APCs), an increase in the frequency of CD103+ DCs, and the promotion of clonal expansion of anti-tumour CD8 + T cells with T-cell cytotoxic capabilities (Fig. 3d) [27].